Taken together, these results suggest that TAS-116 enhances apoptosis induced by RAS-RAF-MEK-ERK pathway inhibitors including dabrafenib via mitochondrial damage in MM cells. The gene discussed is RAF1; the disease is Miyoshi myopathy.